Shenandoah Therapeutics

South San Francisco, CA · Founded 2022 · Privately Held (backing)

Developer of an oncology technology platform designed for cancer treatment. Shenandoah Therapeutics is based in South San Francisco, CA and was founded in 2022. Its last reported valuation was $37 million in Mar 2025. It has raised $21.5 million across 1 recorded round; the latest was a $21.5 million early-stage round in May 2025.

Last reported valuation
$37.0M
Oct 2026
Priced at
—
Total raised
$21.5M
Last round
Early Stage VC
May 2025
What is Shenandoah Therapeutics worth?
$37.0Mlast reported valuation · Oct 2026

Shenandoah Therapeutics's last reported valuation, Mar 2025. Nothing priced has surfaced since.

Private Market View
More of Shenandoah Therapeutics with a free Private Market View account
  • ·Watch Shenandoah Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 40 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free Private Market View account.Unlock the axis

Membership and data by Private Market View

Shenandoah Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC$21.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Shenandoah Therapeutics valuation

Shenandoah Therapeutics's last reported valuation was $37 million in Mar 2025. No priced round, secondary trade or fund mark has surfaced since.

How much has Shenandoah Therapeutics raised?

Shenandoah Therapeutics has raised $21.5 million across 1 recorded round since 2025. The largest was a $21.5 million early-stage round in May 2025.

Shenandoah Therapeutics has filed 1 Form D with the SEC, most recently in May 2025 ($21.5 million sold to 12 investors).

How Shenandoah Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Shenandoah Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Shenandoah Therapeutics

What is Shenandoah Therapeutics worth?
Shenandoah Therapeutics is valued at $37.0M as of Oct 2026. Shenandoah Therapeutics's last reported valuation, Mar 2025. Nothing priced has surfaced since.
How much has Shenandoah Therapeutics raised?
Shenandoah Therapeutics has raised $21.5M in total funding across 1 recorded rounds.
When did Shenandoah Therapeutics last raise?
Shenandoah Therapeutics last raised in May 2025 (Early Stage VC), raising $21.5M.